BC
ANAB icon

Burney Company’s AnaptysBio ANAB Stock Holding History

Burney Company’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
+22,557
New +$1.37M 0.04% 287

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Burney Company's ANAB Position: Q2 2026 in Review

Burney Company opened a new position in AnaptysBio (ANAB) in Q2 2026: 22,557 shares worth $1.52M. The stake represents 0.04% of the portfolio and ranks #287 among its holdings.

214 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Burney Company held 22,557 shares of AnaptysBio worth $1.52M as of Q2 2026.
  • AnaptysBio was a new Burney Company position in Q2 2026.
  • AnaptysBio made up 0.04% of Burney Company's portfolio in Q2 2026, its #287 holding.
  • 214 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.